H4382

Nonprescription Ephedrine Products

Complete·6/3/26

South Carolina H4382 amends the sale of nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine by requiring monthly.

South Carolina H4382 amends the sale of nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine by requiring manufacturers to pay monthly fees to the data collection system. Retailers must report sales to this system, and if a stop sale alert is triggered, the sale cannot be completed unless the purchaser signs an electronic log. The system collects data in real time and generates alerts for violations. Retailers and manufacturers face fines for violations, and immunity from civil liability applies to those who release information in good faith.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

Roll Call Votes

111 Yea

RRDRRRRRRRRRRDRDRRDRRDRRRRRRRRRDRDDRRDRDRRDRRDRRRDRRRRDDRDRRDDRRRRRDRRRRRRRRRRRRDDRDDRRDRRRRDRRRDRDRRRRDRRDRRRR

0 Nay

9 Not Voting

RRDDDRDDR

4 Absent

DDRR

Calendar

May 7

9:00 AM

Senate Medical Affairs Committee

May 6

9:00 AM

Senate Medical Affairs Subcommittee on 607, 1158, 4382, 4641

History

Jun 3

Act No. 235

May 19

Signed By Governor

May 15

Ratified R 248